It is important to highlight that TRPS1 immunohistochemical marker is commonly expressed in breast carcinoma, MPD and EMPD, as the present case demonstrates, but has been reported to be positive in cutaneous carcinoma in situ as well [20]. Here, TRPS1 is linked to skin carcinoma in situ.